Patent applications and USPTO patent grants for JIANGSU ASCENTAGE BIOMED DEVELOPMENT INC..The latest application filed is for "bisdiazabicyclo compound for treating and/or preventing hepatitis virus-related diseases or disorders".
Patent | Date |
---|---|
Bisdiazabicyclo Compound For Treating And/or Preventing Hepatitis Virus-related Diseases Or Disorders App 20220296571 - Zhai; Yifan ;   et al. | 2022-09-22 |
Bisdiazabicyclo compound for treatment and/or prevention of hepatitis virus-related diseases or disorders Grant 11,298,339 - Zhai , et al. April 12, 2 | 2022-04-12 |
Bisdiazabicyclo Compound For Treatment And/or Prevention Of Hepatitis Virus-related Diseases Or Disorders App 20210290594 - Zhai; Yifan ;   et al. | 2021-09-23 |
Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors Grant 9,783,539 - Chen , et al. October 10, 2 | 2017-10-10 |
Indoloquinolone Compounds As Anaplastic Lymphoma Kinase (alk) Inhibitors App 20170066761 - CHEN; Jianyong ;   et al. | 2017-03-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.